Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $27.07 million.

For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.